Packaged Foods
Compare Stocks
5 / 10Stock Comparison
PAVS vs GFAI vs BCO vs TAOP vs ARMK
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Security & Protection Services
Software - Infrastructure
Specialty Business Services
PAVS vs GFAI vs BCO vs TAOP vs ARMK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaged Foods | Security & Protection Services | Security & Protection Services | Software - Infrastructure | Specialty Business Services |
| Market Cap | $70K | $10M | $4.44B | $1M | $11.84B |
| Revenue (TTM) | $13M | $72M | $5.39B | $36M | $18.79B |
| Net Income (TTM) | $-27M | $-24M | $180M | $-7M | $317M |
| Gross Margin | 11.1% | 15.1% | 26.1% | 14.9% | 7.0% |
| Operating Margin | -10.3% | -27.4% | 10.7% | -15.7% | 4.2% |
| Forward P/E | 0.0x | — | 11.7x | — | 20.3x |
| Total Debt | $2M | $3M | $4.93B | $10M | $5.72B |
| Cash & Equiv. | $261K | $22M | $2.27B | $2M | $639M |
PAVS vs GFAI vs BCO vs TAOP vs ARMK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| Paranovus Entertain… (PAVS) | 100 | 0.0 | -100.0% |
| Guardforce AI Co., … (GFAI) | 100 | 0.6 | -99.4% |
| The Brink's Company (BCO) | 100 | 156.7 | +56.7% |
| Taoping Inc. (TAOP) | 100 | 0.1 | -99.9% |
| Aramark (ARMK) | 100 | 182.1 | +82.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PAVS vs GFAI vs BCO vs TAOP vs ARMK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PAVS ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 1.51, Low D/E 8.1%, current ratio 1.12x
- Lower P/E (0.0x vs 20.3x)
GFAI lags the leaders in this set but could rank higher in a more targeted comparison.
BCO carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 6 yrs, beta 1.10, yield 0.9%
- 293.0% 10Y total return vs ARMK's 97.1%
- Beta 1.10, yield 0.9%, current ratio 1.51x
- 3.3% margin vs PAVS's -211.2%
Among these 5 stocks, TAOP doesn't own a clear edge in any measured category.
ARMK is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 6.4%, EPS growth 23.2%, 3Y rev CAGR 10.6%
- 6.4% revenue growth vs PAVS's -98.9%
- Beta 0.71 vs GFAI's 2.31
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.4% revenue growth vs PAVS's -98.9% | |
| Value | Lower P/E (0.0x vs 20.3x) | |
| Quality / Margins | 3.3% margin vs PAVS's -211.2% | |
| Stability / Safety | Beta 0.71 vs GFAI's 2.31 | |
| Dividends | 0.9% yield, 6-year raise streak, vs ARMK's 0.9%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +19.4% vs PAVS's -99.9% | |
| Efficiency (ROA) | 2.5% ROA vs PAVS's -94.4%, ROIC 14.3% vs -27.1% |
PAVS vs GFAI vs BCO vs TAOP vs ARMK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
PAVS vs GFAI vs BCO vs TAOP vs ARMK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BCO leads in 3 of 6 categories
ARMK leads 2 • PAVS leads 0 • GFAI leads 0 • TAOP leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BCO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARMK is the larger business by revenue, generating $18.8B annually — 1475.1x PAVS's $13M. BCO is the more profitable business, keeping 3.3% of every revenue dollar as net income compared to PAVS's -2.1%. On growth, PAVS holds the edge at +180.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $13M | $72M | $5.4B | $36M | $18.8B |
| EBITDAEarnings before interest/tax | $531,773 | -$12M | $797M | -$4M | $1.3B |
| Net IncomeAfter-tax profit | -$27M | -$24M | $180M | -$7M | $317M |
| Free Cash FlowCash after capex | -$3M | -$6M | $544M | -$3M | $257M |
| Gross MarginGross profit ÷ Revenue | +11.1% | +15.1% | +26.1% | +14.9% | +7.0% |
| Operating MarginEBIT ÷ Revenue | -10.3% | -27.4% | +10.7% | -15.7% | +4.2% |
| Net MarginNet income ÷ Revenue | -2.1% | -32.9% | +3.3% | -19.6% | +1.7% |
| FCF MarginFCF ÷ Revenue | -23.5% | -8.8% | +10.1% | -8.1% | +1.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +180.3% | +3.6% | +10.3% | -2.6% | +6.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +76.9% | +38.9% | -35.3% | -51.7% | -7.7% |
Valuation Metrics
Evenly matched — PAVS and BCO each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 22.9x trailing earnings, BCO trades at a 38% valuation discount to ARMK's 36.9x P/E. On an enterprise value basis, BCO's 8.0x EV/EBITDA is more attractive than ARMK's 13.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $70,061 | $10M | $4.4B | $1M | $11.8B |
| Enterprise ValueMkt cap + debt − cash | $2M | -$9M | $7.1B | $9M | $16.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -0.89x | 22.93x | -0.16x | 36.93x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.00x | — | 11.73x | — | 20.26x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.38x | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 8.01x | — | 13.35x |
| Price / SalesMarket cap ÷ Revenue | 0.98x | 0.28x | 0.84x | 0.04x | 0.64x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.16x | 11.14x | 0.08x | 3.81x |
| Price / FCFMarket cap ÷ FCF | — | — | 10.17x | — | 26.06x |
Profitability & Efficiency
BCO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BCO delivers a 45.6% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-116 for PAVS. PAVS carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to BCO's 12.10x. On the Piotroski fundamental quality scale (0–9), ARMK scores 7/9 vs TAOP's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -116.2% | -69.7% | +45.6% | -46.7% | +9.8% |
| ROA (TTM)Return on assets | -94.4% | -50.2% | +2.5% | -21.7% | +2.4% |
| ROICReturn on invested capital | -27.1% | -41.6% | +14.3% | -27.1% | +7.3% |
| ROCEReturn on capital employed | -39.5% | -19.1% | +12.1% | -38.0% | +8.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 2 | 7 |
| Debt / EquityFinancial leverage | 0.08x | 0.08x | 12.10x | 0.50x | 1.81x |
| Net DebtTotal debt minus cash | $2M | -$19M | $2.7B | $8M | $5.1B |
| Cash & Equiv.Liquid assets | $261,355 | $22M | $2.3B | $2M | $639M |
| Total DebtShort + long-term debt | $2M | $3M | $4.9B | $10M | $5.7B |
| Interest CoverageEBIT ÷ Interest expense | -11.83x | -167.24x | 3.90x | -52.63x | 2.20x |
Total Returns (Dividends Reinvested)
ARMK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARMK five years ago would be worth $17,052 today (with dividends reinvested), compared to $0 for PAVS. Over the past 12 months, BCO leads with a +19.4% total return vs PAVS's -99.9%. The 3-year compound annual growth rate (CAGR) favors ARMK at 23.3% vs PAVS's -93.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -94.8% | -26.3% | -7.3% | -6.8% | +23.5% |
| 1-Year ReturnPast 12 months | -99.9% | -53.2% | +19.4% | -78.3% | +19.0% |
| 3-Year ReturnCumulative with dividends | -100.0% | -93.8% | +75.3% | -99.3% | +87.4% |
| 5-Year ReturnCumulative with dividends | -100.0% | -99.5% | +39.3% | -99.9% | +70.5% |
| 10-Year ReturnCumulative with dividends | -100.0% | -99.5% | +293.0% | -99.9% | +97.1% |
| CAGR (3Y)Annualised 3-year return | -93.2% | -60.4% | +20.6% | -80.9% | +23.3% |
Risk & Volatility
ARMK leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ARMK is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than GFAI's 2.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ARMK currently trades 96.1% from its 52-week high vs PAVS's 0.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.53x | 2.31x | 1.10x | 2.26x | 0.78x |
| 52-Week HighHighest price in past year | $1488.00 | $1.50 | $136.37 | $20.10 | $46.88 |
| 52-Week LowLowest price in past year | $1.02 | $0.38 | $80.10 | $1.18 | $35.07 |
| % of 52W HighCurrent price vs 52-week peak | +0.1% | +31.5% | +79.0% | +6.4% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 31.9 | 47.0 | 52.0 | 53.1 | 62.0 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 378K | 543K | 20K | 2.2M |
Analyst Outlook
BCO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BCO as "Buy", ARMK as "Buy". Consensus price targets imply 51.3% upside for BCO (target: $163) vs 4.7% for ARMK (target: $47). For income investors, BCO offers the higher dividend yield at 0.93% vs ARMK's 0.92%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | — | $163.00 | — | $47.20 |
| # AnalystsCovering analysts | — | — | 9 | — | 24 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.9% | — | +0.9% |
| Dividend StreakConsecutive years of raises | 0 | — | 6 | 1 | 1 |
| Dividend / ShareAnnual DPS | — | — | $1.00 | — | $0.41 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +4.7% | 0.0% | +1.2% |
BCO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARMK leads in 2 (Total Returns, Risk & Volatility). 1 tied.
PAVS vs GFAI vs BCO vs TAOP vs ARMK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PAVS or GFAI or BCO or TAOP or ARMK a better buy right now?
For growth investors, Aramark (ARMK) is the stronger pick with 6.
4% revenue growth year-over-year, versus -98. 9% for Paranovus Entertainment Technology Ltd. (PAVS). The Brink's Company (BCO) offers the better valuation at 22. 9x trailing P/E (11. 7x forward), making it the more compelling value choice. Analysts rate The Brink's Company (BCO) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PAVS or GFAI or BCO or TAOP or ARMK?
On trailing P/E, The Brink's Company (BCO) is the cheapest at 22.
9x versus Aramark at 36. 9x. On forward P/E, Paranovus Entertainment Technology Ltd. is actually cheaper at 0. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PAVS or GFAI or BCO or TAOP or ARMK?
Over the past 5 years, Aramark (ARMK) delivered a total return of +70.
5%, compared to -100. 0% for Paranovus Entertainment Technology Ltd. (PAVS). Over 10 years, the gap is even starker: BCO returned +293. 0% versus PAVS's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PAVS or GFAI or BCO or TAOP or ARMK?
By beta (market sensitivity over 5 years), Aramark (ARMK) is the lower-risk stock at 0.
78β versus Guardforce AI Co. , Limited's 2. 31β — meaning GFAI is approximately 197% more volatile than ARMK relative to the S&P 500. On balance sheet safety, Paranovus Entertainment Technology Ltd. (PAVS) carries a lower debt/equity ratio of 8% versus 12% for The Brink's Company — giving it more financial flexibility in a downturn.
05Which is growing faster — PAVS or GFAI or BCO or TAOP or ARMK?
By revenue growth (latest reported year), Aramark (ARMK) is pulling ahead at 6.
4% versus -98. 9% for Paranovus Entertainment Technology Ltd. (PAVS). On earnings-per-share growth, the picture is similar: Paranovus Entertainment Technology Ltd. grew EPS 96. 4% year-over-year, compared to -1870. 0% for Taoping Inc.. Over a 3-year CAGR, ARMK leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PAVS or GFAI or BCO or TAOP or ARMK?
The Brink's Company (BCO) is the more profitable company, earning 3.
8% net margin versus -110. 3% for Paranovus Entertainment Technology Ltd. — meaning it keeps 3. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCO leads at 11. 3% versus -94. 8% for PAVS. At the gross margin level — before operating expenses — BCO leads at 25. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PAVS or GFAI or BCO or TAOP or ARMK more undervalued right now?
On forward earnings alone, Paranovus Entertainment Technology Ltd.
(PAVS) trades at 0. 0x forward P/E versus 20. 3x for Aramark — 20. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BCO: 51. 3% to $163. 00.
08Which pays a better dividend — PAVS or GFAI or BCO or TAOP or ARMK?
In this comparison, BCO (0.
9% yield), ARMK (0. 9% yield) pay a dividend. PAVS, GFAI, TAOP do not pay a meaningful dividend and should not be held primarily for income.
09Is PAVS or GFAI or BCO or TAOP or ARMK better for a retirement portfolio?
For long-horizon retirement investors, Aramark (ARMK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
78), 0. 9% yield). Taoping Inc. (TAOP) carries a higher beta of 2. 26 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ARMK: +97. 2%, TAOP: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PAVS and GFAI and BCO and TAOP and ARMK?
These companies operate in different sectors (PAVS (Consumer Defensive) and GFAI (Industrials) and BCO (Industrials) and TAOP (Technology) and ARMK (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
BCO, ARMK pay a dividend while PAVS, GFAI, TAOP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.